KalshiBeschikbaarheid controlerenKYC vereist2% kostenGeverifieerde afwikkelingsgegevensGrof gekalibreerdHuidige impliciete kansBefore October 2027 90%Koploper van 5 uitkomsten
Marktkwaliteit
48 / 100
Lage kwaliteit24u volume
€ 0
Liquiditeit
€ 6,5K
Gemiddelde liquiditeitBied / Laat
32.0% / 36.0%
Spread
4.0 pt
Gematigde spreadMarktdata
Bijgewerkt 13 minuten geleden
16 mei 26, 2:301 jan 27, 4:59
Trends
Alleen virtueel geld, geen echt geldGeen financieel advies
Gekozen uitkomst
Before Jan 1, 202736%
Volumetrend
$132 jul20d aan data27 jul
Gerelateerde Markten
Hantavirus pandemic in 2026?
€ 98,4KJa: 3%
POLYMARKET
POLYMARKET
# of views of MrBeast video day 3?
€ 6,9K26-27M: 78%POLYMARKET
POLYMARKET
New pandemic in 2026?
€ 5,2KJa: 9%POLYMARKET
POLYMARKET
Measles cases in 2026?
€ 2,4KAbove 3000: 94%KALSHI
KALSHI
Pandemic in 2026?
€ 2KJa: 5%KALSHI
KALSHI
Cyclosporiasis cases reported in the US in 2026?
€ 1,2KAbove 20k: 34%KALSHI
KALSHIActief in deze onderwerpen
Regels
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.